Bharat Biotech's Covaxin is overall 77.8 per cent effective "against symptomatic COVID-19", the vaccine maker said today in a statement, citing the data from the third phase of clinical trials. The...
from NDTV News - Special https://ift.tt/2TyByf1
via IFTTT
Friday, 2 July 2021
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment